The Canadian dollar was little changed against its U.S. counterpart on Thursday, holding on to its previous day's gains as oil prices rose and investors assessed a sharp rise in the number of coronavirus deaths and infections.
(RTTNews) - CRISPR Therapeutics AG (CRSP), which is down more than 20% from its yearly high of $74, recorded last December, expects 2020 to have the potential to be a pivotal year in the company's growth.
For an event meant to showcase the power of telecoms, cancelling this year's Mobile World Congress in Barcelona without a back-up plan has perplexed many in the trillion-dollar sector.
(RTTNews) - PennyMac Financial Services, Inc. (PFSI) shares are sliding on Thursday morning.
The mortgage banking company announced on Thursday that BlackRock, Inc. (BLK) has contributed its remaining 20 percent ownership stake in PFSI to two charitable entities, the BlackRoc
Spain's High Court on Thursday ordered Emilio Lozoya, former chief executive of Mexican state oil firm Pemex, to be held in a Spanish jail pending an extradition request from Mexico where he faces corruption charges.
(RTTNews) - Shares of Tempur Sealy International Inc. (TPX) touched a 52-week high of $100.35 today, after the company reported stellar Q4 results. The stock has been trading in a range of $53.69 - $100.35 in the past one year.
(RTTNews) - Dominion Energy said it will build, own and operate solar facility in Greensville County, Va. Facebook will purchase the environmental attributes generated by the solar facility.
(RTTNews) - Shares of Medtronic plc (MDT) has pared initial losses and is now declining 0.5 percent in the morning trade on Thursday, at $115.90, after the medical device company said it has agreed to acquire privately held, London-based Digital Surgery.
Losing a job is almost always traumatic. In your 50s, job loss can be devastating — and devastatingly common. More than half the workers who entered their 50s with stable,…
The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The following are today's upgrades for Validea's Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.